2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Sunday, October 21, 2018

9:00AM-11:00AM: Antiphospholipid Syndrome Poster

9:00AM-11:00AM: B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

9:00AM-11:00AM: Education Poster

9:00AM-11:00AM: Epidemiology and Public Health Poster I – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

9:00AM-11:00AM: Fibromyalgia and Other Clinical Pain Syndromes Poster

9:00AM-11:00AM: Fibromyalgia and Other Clinical Pain Syndromes Poster – ARHP

9:00AM-11:00AM: Health Services Research Poster I – ACR/ARHP

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster

9:00AM-11:00AM: Healthcare Disparities in Rheumatology Poster – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster I: MRI

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster I

9:00AM-11:00AM: Measures and Measurements of Healthcare Quality Poster – ARHP

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster I: Checkpoint Inhibitors, Retroperitoneal Fibrosis

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster – ARHP

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster I: Clinical Features and Disease Course

9:00AM-11:00AM: Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP

9:00AM-11:00AM: Osteoarthritis – Clinical Poster I

9:00AM-11:00AM: Pain Mechanisms – Basic and Clinical Science Poster

9:00AM-11:00AM: Pain Mechanisms – Basic and Clinical Science Poster – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster I: Lupus, Sjögren’s Disease, and Myositis

9:00AM-11:00AM: Rheumatoid Arthritis – Animal Models Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster I – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Basic Science Poster I

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster I

9:00AM-11:00AM: T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster

9:00AM-11:00AM: Vasculitis Poster I: Non-ANCA-Associated and Related Disorders

11:00AM-12:30PM: 3S037 ACR Abstract: Plenary Session I (835–839)

12:00PM-2:00PM: 3S041 ACR/ARHP: Patient Perspectives Poster Session

2:30PM-4:00PM: 3S079 ACR Abstract: Antiphospholipid Syndrome (851–856)

2:30PM-4:00PM: 3S080 ACR Abstract: Cytokines & Cell Trafficking (840–845)

2:30PM-4:00PM: 3S081 ACR Abstract: Education (857–862)

2:30PM-4:00PM: 3S082 ACR Abstract: Imaging of Rheumatic Diseases I: MRI & CT (863–868)

2:30PM-4:00PM: 3S083 ACR Abstract: Metabolic & Crystal Arthropathies: Comorbidities & Outcomes (869–874)

2:30PM-4:00PM: 3S084 ACR Abstract: Muscle Biology, Myositis & Myopathies I: Biomarkers (875–879)

2:30PM-4:00PM: 3S085 ACR Abstract: Osteoarthritis & Joint Biology–Basic Science (846–850)

2:30PM-4:00PM: 3S086 ACR Abstract: RA–DX, Manifestations, & Outcomes I: Other Co-Morbidities (880–885)

2:30PM-4:00PM: 3S087 ACR Abstract: RA–Treatments I: JAK Inhibitors (886–891)

2:30PM-4:00PM: 3S088 ACR Abstract: Spondyloarthritis Incl PsA–Clinical I: Axial SpA Epidemiology (892–897)

2:30PM-4:00PM: 3S089 ACR Abstract: Systemic Sclerosis & Rel D/O–Clinical I: Clinical Trials I (898–903)

2:30PM-4:00PM: 3S090 ACR Abstract: Vasculitis–ANCA-Assocd (904–909)

2:30PM-4:00PM: 3S093 ACR/ARHP Abstract: Epidemiology & Pub Health (910–915)

4:30PM-6:00PM: 3S102 ACR Abstract: Epidemiology & Pub Health I: Morbidity & Mortality (940–945)

4:30PM-6:00PM: 3S103 ACR Abstract: Genetics, Genomics & Proteomics: Precision Medicine (916–921)

4:30PM-6:00PM: 3S104 ACR Abstract: Infection-Related Rheumatic Disease (946–951)

4:30PM-6:00PM: 3S105 ACR Abstract: Osteoarthritis–Clinical (952–957)

4:30PM-6:00PM: 3S106 ACR Abstract: Pediatric Rheumatology–Basic Science (922–927)

4:30PM-6:00PM: 3S107 ACR Abstract: RA–Etiology & Pathogenesis I (928–933)

4:30PM-6:00PM: 3S108 ACR Abstract: RA–Treatments II: Safety (958–963)

4:30PM-6:00PM: 3S109 ACR Abstract: SLE–Animal Models (934–939)

4:30PM-6:00PM: 3S110 ACR Abstract: SLE–Clinical I: Clinical Trials (970–975)

4:30PM-6:00PM: 3S111 ACR Abstract: Spondyloarthritis Incl PsA–Clinical II: PsA Epidemiology (964–969)

4:30PM-6:00PM: 3S115 ACR/ARHP Abstract: Pediatric Rheum (976–981)

Monday, October 22, 2018

9:00AM-11:00AM: Cytokines and Cell Trafficking Poster

9:00AM-11:00AM: Epidemiology and Public Health Poster II – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster II: Gout, Ankylosing Spondylitis, Osteoarthritis, Osteoporosis, Pain, and Function

9:00AM-11:00AM: Health Services Research Poster II – ACR/ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II – ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster II: Ultrasound

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster

9:00AM-11:00AM: Infection-related Rheumatic Disease Poster – ARHP

9:00AM-11:00AM: Innate Immunity Poster

9:00AM-11:00AM: Measures and Measurement of Healthcare Quality Poster II

9:00AM-11:00AM: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster I

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster II: Interstitial Lung Disease, Still's Disease, FMF, Polychondritis

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster II: Basic and Translational Science

9:00AM-11:00AM: Osteoarthritis – Clinical Poster – ARHP

9:00AM-11:00AM: Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Osteoarthritis and Joint Biology – Basic Science Poster I

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster I – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster I: Patient-Reported Outcomes

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster I – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II: Autoinflammatory Disorders, Scleroderma, and Miscellaneous

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestions, and Outcomes Poster – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster II – ARHP

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster II: PROs, Safety and Comorbidity

9:00AM-11:00AM: Sjögren's Syndrome – Basic and Clinical Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster – ARHP

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster – ARHP

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster II: Biomarkers and Outcomes

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster II

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Basic Science Poster II

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster II

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster I

9:00AM-11:00AM: Vasculitis Poster II: Behҫet’s Disease and IgG4-Related Disease

11:00AM-12:30PM: 4M042 ACR Abstract: Plenary Session II (1816–1821)

2:30PM-4:00PM: 4M081 ACR Abstract: Edmond L. Dubois, MD Memorial Lecture: SLE–Clinical (1870–1874)

2:30PM-4:00PM: 4M082 ACR Abstract: Fibromyalgia & Other Clinical Pain Syndromes (1834–1839)

2:30PM-4:00PM: 4M083 ACR Abstract: Healthcare Disparities in Rheumatology (1840–1845)

2:30PM-4:00PM: 4M084 ACR Abstract: Pediatric Rheum–Clinical I: Outcomes & Comorbidities (1846–1851)

2:30PM-4:00PM: 4M085 ACR Abstract: RA–Animal Models (1822–1827)

2:30PM-4:00PM: 4M086 ACR Abstract: RA–DX, Manifestations, & Outcomes II: DX & Prognosis I (1858–1863)

2:30PM-4:00PM: 4M087 ACR Abstract: Reproductive Issues in Rheumatic Disorders (1852–1857)

2:30PM-4:00PM: 4M088 ACR Abstract: Spondyloarthritis Incl PsA–Basic Science (1828–1833)

2:30PM-4:00PM: 4M089 ACR Abstract: Spondyloarthritis Incl PsA–Clinical III: Treatment of Axial SpA (1864–1869)

2:30PM-4:00PM: 4M090 ACR Abstract: Systemic Sclerosis & Rel D/O–Clinical II: Clinical Trials II (1875–1880)

2:30PM-4:00PM: 4M091 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os I: Population-Based Studies(1881–1886)

2:30PM-4:00PM: 4M094 ACR/ARHP Abstract: Health Services Research I: Focus on Big Data (1887–1892)

4:30PM-6:00PM: 4M101 ACR Abstract: Epidemiology & Pub Health II: RA Risk: Education, Obesity, Smoking, or Biomarkers? (1905–1910)

4:30PM-6:00PM: 4M102 ACR Abstract: Misc Rheum & Inflam DZ I: DADA2, Cardiac Sarcoid,Cancer Immunotherapy(1911–1916)

4:30PM-6:00PM: 4M103 ACR Abstract: Pain Mechanisms–Basic & Clinical Science (1917–1922)

4:30PM-6:00PM: 4M104 ACR Abstract: Patient Outcomes, Preferences, & Attitudes I: Beliefs & Behaviors (1923–1928)

4:30PM-6:00PM: 4M105 ACR Abstract: RA–DX, Manifestations, & Outcomes III: Diagnosis & Prognosis II (1929–1934)

4:30PM-6:00PM: 4M106 ACR Abstract: RA–Treatments III: New Compounds & Biosimilars (1935–1940)

4:30PM-6:00PM: 4M107 ACR Abstract: SLE–Clinical II: Renal & Neuropsychiatric Disease in SLE (1941–1945)

4:30PM-6:00PM: 4M108 ACR Abstract: SLE–Etiology & Pathogenesis I (1893–1898)

4:30PM-6:00PM: 4M109 ACR Abstract: Systemic Sclerosis & Rel D/Os–Basic Science (1899–1904)

4:30PM-6:00PM: 4M114 ACR/ARHP Abstract: Orthopedics, Low Back Pain & Rehabilitation (1952–1957)

4:30PM-6:00PM: 4M117 ARHP Abstract: Pain, Anxiety, & Depression–ARHP I (1946–1951)

Tuesday, October 23, 2018

9:00AM-11:00AM: Epidemiology and Public Health Poster III – ARHP

9:00AM-11:00AM: Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases

9:00AM-11:00AM: Genetics, Genomics and Proteomics Poster

9:00AM-11:00AM: Health Services Research Poster III – ACR/ARHP

9:00AM-11:00AM: Imaging of Rheumatic Diseases Poster III: Other Modalities

9:00AM-11:00AM: Late-Breaking Abstract Poster Session

9:00AM-11:00AM: Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster II

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster – ARHP

9:00AM-11:00AM: Miscellaneous Rheumatic and Inflammatory Diseases Poster III: Sarcoid, Inflammatory Eye Disease, and Autoinflammatory Disease

9:00AM-11:00AM: Muscle Biology, Myositis and Myopathies Poster III: Treatment and Classification Criteria

9:00AM-11:00AM: Osteoarthritis and Joint Biology – Basic Science Poster II

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster

9:00AM-11:00AM: Osteoporosis and Metabolic Bone Disease – Basic and Clinical Science Poster – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster II – ARHP

9:00AM-11:00AM: Patient Outcomes, Preferences, and Attitudes Poster II: Patient Perspectives

9:00AM-11:00AM: Pediatric Rheumatology – Basic Science Poster

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster II – ARHP

9:00AM-11:00AM: Pediatric Rheumatology – Clinical Poster III: Juvenile Idiopathic Arthritis and Uveitis

9:00AM-11:00AM: Reproductive Issues in Rheumatic Disorders Poster

9:00AM-11:00AM: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III: Complications of Therapy, Outcomes, and Measures

9:00AM-11:00AM: Rheumatoid Arthritis – Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Rheumatoid Arthritis – Treatments Poster III: Biosimilars and New Compounds

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

9:00AM-11:00AM: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Animal Models Poster

9:00AM-11:00AM: Systemic Lupus Erythematosus – Clinical Poster III: Treatment

9:00AM-11:00AM: Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster III

9:00AM-11:00AM: Systemic Sclerosis and Related Disorders – Clinical Poster III

9:00AM-11:00AM: Vasculitis – ANCA-Associated Poster II

9:00AM-11:00AM: Vasculitis Poster III: Immunosuppressive Therapy in Giant Cell Arteritis and Polymyalgia Rheumatica

11:00AM-12:30PM: 5T046 ACR Abstract: Plenary Session III (2785–2790)

2:30PM-4:00PM: 5T085 ACR Abstract: B Cell Biology & Targets in Autoimmune & Inflammatory Disease (2791–2796)

2:30PM-4:00PM: 5T086 ACR Abstract: Epidemiology & Pub Health III: SLE & SSc, Big Data & Large Cohorts (2802–2807)

2:30PM-4:00PM: 5T087 ACR Abstract: Osteoporosis & Metabolic Bone Disease–Basic & Clinical Science (2808–2813)

2:30PM-4:00PM: 5T088 ACR Abstract: RA–DX, Manifestations, & Outcomes IV: CV Co-Morbidities (2814–2819)

2:30PM-4:00PM: 5T089 ACR Abstract: RA–Treatments IV: Strategy (2820–2825)

2:30PM-4:00PM: 5T090 ACR Abstract: SLE–Clinical III: Translational Aspects (2832–2837)

2:30PM-4:00PM: 5T091 ACR Abstract: Spondyloarthritis Incl PsA–Clinical IV: Comorbid/Related Conditions(2826–2831)

2:30PM-4:00PM: 5T092 ACR Abstract: T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2797–2801)

2:30PM-4:00PM: 5T093 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os II: Novel Diagnostics & THRs (2838–2843)

2:30PM-4:00PM: 5T099 ARHP Abstract: Clinical Aspects & Outcomes Research–ARHP II (2844–2849)

4:00PM-6:00PM: 5T113 Abstracts: Late-Breaking Abstract Session

4:30PM-6:00PM: 5T105 ACR Abstract: Innate Immunity (2850–2855)

4:30PM-6:00PM: 5T106 ACR Abstract: Measures of Healthcare Quality I: QI in RA (2856–2861)

4:30PM-6:00PM: 5T107 ACR Abstract: Pediatric Rheum–Clinical II: Treatment Update (2862–2867)

4:30PM-6:00PM: 5T108 ACR Abstract: RA–DX, Manifestations, & Outcomes V: Outcomes Measures (2868–2873)

4:30PM-6:00PM: 5T109 ACR Abstract: RA–Treatments V: Beyond Individual Compounds (2874–2879)

4:30PM-6:00PM: 5T110 ACR Abstract: Sjögren's Syndrome–Basic & Clinical Science (2880–2885)

4:30PM-6:00PM: 5T111 ACR Abstract: SLE–Clinical IV: Clinical Outcomes (2892–2897)

4:30PM-6:00PM: 5T112 ACR Abstract: Spondyloarthritis Incl PsA–Clinical V: Tx of PsA & Peripheral SpA (2886–2891)

Wednesday, October 24, 2018

9:00AM-10:30AM: 6W006 ACR Abstract: Imaging of Rheumatic Diseases II: Ultrasound (2904–2909)

9:00AM-10:30AM: 6W007 ACR Abstract: Patient Outcomes, Preferences, & Attitudes II: PROs (2910–2915)

9:00AM-10:30AM: 6W008 ACR Abstract: Pediatric Rheum–Clinical III: Assessment Tools & Biomarkers (2916–2921)

9:00AM-10:30AM: 6W009 ACR Abstract: RA–Etiology & Pathogenesis II (2898–2903)

9:00AM-10:30AM: 6W010 ACR Abstract: SLE–Clinical V: Biomarkers, Criteria, & Outcomes (2928–2933)

9:00AM-10:30AM: 6W011 ACR Abstract: Spondyloarthritis Incl PsA–Clinical VI: Imaging of Axial SpA (2922–2927)

9:00AM-10:30AM: 6W012 ACR Abstract: Systemic Sclerosis & Rel D/O III:Cohort Study, Biomarkers, & Response(2934–2939)

9:00AM-10:30AM: 6W016 ARHP Abstract: Interventions & Self-Management–ARHP III (2940–2945)

11:00AM-12:30PM: 6W018 ACR Abstract: Epidemiology & Pub Health IV: Determinants & Consequences of Tx (2952–2957)

11:00AM-12:30PM: 6W019 ACR Abstract: Measures of Healthcare Quality II: QI in SLE, Gout & JIA (2958–2963)

11:00AM-12:30PM: 6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)

11:00AM-12:30PM: 6W021 ACR Abstract: Misc Rheumatic & Inflam DZ II (2970–2975)

11:00AM-12:30PM: 6W022 ACR Abstract: Muscle Biology, Myositis & Myopathies II: Clinical & Misc Topics (2976–2981)

11:00AM-12:30PM: 6W023 ACR Abstract: RA–DX, Manifestations, & Outcomes VI: Outcomes Reports (2982–2987)

11:00AM-12:30PM: 6W024 ACR Abstract: SLE–Etiology & Pathogenesis II (2946–2951)

11:00AM-12:30PM: 6W025 ACR Abstract: Vasculitis–Non-ANCA-Assocd & Rel D/Os III: Clinical Subtype & Outcome(2988–2993)

11:00AM-12:30PM: 6W027 ACR/ARHP Abstract: Health Services Research II: Economic & Clinical Implications (2994–2999)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].